| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Animal Models |
From the Departments of Ophthalmology andNeuroscience*
and Molecular Biology andGenetics,
The Johns Hopkins University Schoolof Medicine, Baltimore, Maryland; and the Jules Stein Eye Institute andthe Department of Neurobiology and Brain ResearchInstitute,
University of California at LosAngeles School of Medicine, Los Angeles, California
Abstract
Transgenic mice with vascular endothelial growth factor (VEGF) driven by the rhodopsin promoter (rho/VEGF mice) develop neovascularization that originates from the deep capillary bed of the retina and grows into the subretinal space. In rho/VEGF mice, VEGF expression in photoreceptors begins between postnatal days 5 and 7, the period when the deep capillary bed is developing. An important question is whether or not the developmental stage of the deep capillary bed is critical for occurrence of neovascularization. Also, although rho/VEGF mice are extremely useful for the study of ocular neovascularization, there are some applications for which the early onset of VEGF expression is a disadvantage. In this study, we used the reverse tetracycline transactivator (rtTA) inducible promoter system coupled to either the rhodopsin or interphotoreceptor retinoid-binding protein (IRBP) promoter to control the time of onset of VEGF transgene expression in photoreceptors. In the absence of doxycycline, adult double-transgenic rho/rtTA-TRE/VEGF or IRBP/rtTA-TRE/VEGF mice showed little VEGF transgene expression and no phenotype. The addition of doxycycline to the drinking water resulted in prominent transgene expression and evidence of neovascularization within 3 to 4 days. Like rho/VEGF mice, the neovascularization originated from the deep capillary bed of the retina, but it was more extensive and caused outer retinal folds followed by total retinal detachment. Real-time polymerase chain reaction and enzyme-linked immunosorbent assay demonstrated that the mice with inducible expression of VEGF that developed retinal detachment had much higher ocular levels of VEGF mRNA and protein compared to rho/VEGF mice that manifest a much milder phenotype. These data demonstrate that regardless of developmental stage of the vascular bed, increased expression of VEGF in the retina is sufficient to cause neovascularization, and high levels of expression cause severe neovascularization and traction retinal detachment. Mice with inducible expression of VEGF in the retina provide a valuable new model of ocular neovascularization.
This article has been cited by other articles:
 |
|
 |
|
  B. Xie, J. Shen, A. Dong, M. Swaim, S. F. Hackett, L. Wyder, S. Worpenberg, S. Barbieri, and P. A. Campochiaro An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization FASEB J, August 1, 2008; 22(8): 2775 - 2783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lima e Silva, J. Shen, S. F. Hackett, S. Kachi, H. Akiyama, K. Kiuchi, K. Yokoi, M. C. Hatara, T. Lauer, S. Aslam, et al. The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization FASEB J, October 1, 2007; 21(12): 3219 - 3230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Harper, L. Yan, R. M. Loureiro, I. Wu, J. Fang, P. A. D'Amore, and M. A. Moses Repression of Vascular Endothelial Growth Factor Expression by the Zinc Finger Transcription Factor ZNF24 Cancer Res., September 15, 2007; 67(18): 8736 - 8741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Saika, O. Yamanaka, I. Nishikawa-Ishida, A. Kitano, K. C. Flanders, Y. Okada, Y. Ohnishi, Y. Nakajima, and K. Ikeda Effect of Smad7 Gene Overexpression on Transforming Growth Factor beta-Induced Retinal Pigment Fibrosis in a Proliferative Vitreoretinopathy Mouse Model Arch Ophthalmol, May 1, 2007; 125(5): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murakami, K. Suzuma, H. Takagi, M. Kita, H. Ohashi, D. Watanabe, T. Ojima, M. Kurimoto, T. Kimura, A. Sakamoto, et al. Time-Lapse Imaging of Vitreoretinal Angiogenesis Originating from Both Quiescent and Mature Vessels in a Novel Ex Vivo System Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5529 - 5536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. van Eeden, L. B. G. Tee, S. Lukehurst, C.-M. Lai, E. P. Rakoczy, L. D. Beazley, and S. A. Dunlop Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4638 - 4645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Campochiaro and the First ARVO/Pfizer Institute Working Group Ocular versus Extraocular Neovascularization: Mirror Images or Vague Resemblances Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 462 - 474. [Full Text] [PDF]
|
|
|
|
|
|
U. F. O. Luhmann, J. Lin, N. Acar, S. Lammel, S. Feil, C. Grimm, M. W. Seeliger, H.-P. Hammes, and W. Berger Role of the Norrie Disease Pseudoglioma Gene in Sprouting Angiogenesis during Development of the Retinal Vasculature Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3372 - 3382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Kerrison, E. J. Duh, Y. Yu, D. C. Otteson, and D. J. Zack A System for Inducible Gene Expression in Retinal Ganglion Cells Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2932 - 2939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C-M Lai, S A Dunlop, L A May, M Gorbatov, M Brankov, W-Y Shen, N Binz, Y K. Lai, C E Graham, C J Barry, et al. Generation of transgenic mice with mild and severe retinal neovascularisation Br. J. Ophthalmol., July 1, 2005; 89(7): 911 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.H. V. Chong, J. Keonin, P. J. Luthert, C. I. Frennesson, D. M. Weingeist, R. L. Wolf, R. F. Mullins, and G. S. Hageman Decreased Thickness and Integrity of the Macular Elastic Layer of Bruch's Membrane Correspond to the Distribution of Lesions Associated with Age-Related Macular Degeneration Am. J. Pathol., January 1, 2005; 166(1): 241 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Baluk, C. G. Lee, H. Link, E. Ator, A. Haskell, J. A. Elias, and D. M. McDonald Regulated Angiogenesis and Vascular Regression in Mice Overexpressing Vascular Endothelial Growth Factor in Airways Am. J. Pathol., October 1, 2004; 165(4): 1071 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Slomiany and S. A. Rosenzweig IGF-1-Induced VEGF and IGFBP-3 Secretion Correlates with Increased HIF-1{alpha} Expression and Activity in Retinal Pigment Epithelial Cell Line D407 Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2838 - 2847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jin, Y. Chen, S. He, S. J. Ryan, and D. R. Hinton Hepatocyte Growth Factor and its Role in the Pathogenesis of Retinal Detachment Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Kelly, S. F. Hackett, K. Hirota, Y. Oshima, Z. Cai, S. Berg-Dixon, A. Rowan, Z. Yan, P. A. Campochiaro, and G. L. Semenza Cell Type-Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1 Circ. Res., November 28, 2003; 93(11): 1074 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Traverso, N. Kinkl, L. Grimm, J. Sahel, and D. Hicks Basic Fibroblast and Epidermal Growth Factors Stimulate Survival in Adult Porcine Photoreceptor Cell Cultures Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4550 - 4558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Schubert, X. Y. Yang, T. T.C. Yang, S. M. Factor, M. P. Lisanti, J. D. Molkentin, M. Rincon, and C.-W. Chow Requirement of transcription factor NFAT in developing atrial myocardium J. Cell Biol., June 9, 2003; 161(5): 861 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Okoye, J. Zimmer, J. Sung, P. Gehlbach, T. Deering, H. Nambu, S. Hackett, M. Melia, N. Esumi, D. J. Zack, et al. Increased Expression of Brain-Derived Neurotrophic Factor Preserves Retinal Function and Slows Cell Death from Rhodopsin Mutation or Oxidative Damage J. Neurosci., May 15, 2003; 23(10): 4164 - 4172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Rakoczy, M. Brankov, A. Fonceca, T. Zaknich, B. C. Rae, and C.-M. Lai Enhanced Recombinant Adeno-Associated Virus-Mediated Vascular Endothelial Growth Factor Expression in the Adult Mouse Retina: A Potential Model for Diabetic Retinopathy Diabetes, March 1, 2003; 52(3): 857 - 863. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
